Neoantigen-pulsed dendritic cells present peptides on HLA class I to prime neoantigen-specific CD8+ T cells; the resulting CTLs kill tumor cells presenting the same peptide–HLA complexes via perforin/granzyme or Fas–FasL, not the dendritic cells expressing HLA I.